Table 2.
Group I BP Up 2.9% (n=49) | Group II BP Down 6.2% (n=107) | Group III BP No Change 90.9% (n=1569) | P Value | |||
---|---|---|---|---|---|---|
I vs III | II vs III | (I and II) vs III | ||||
Cholesterol, mg/dL | 171.32±29.23 | 162.84±30.03 | 160.19±35.11 | .34 | .07 | .06 |
Uric acid, mg/dL | 5.52±1.62 | 5.34±1.42 | 5.11±1.44 | .21 | .16 | .13 |
C‐reactive protein, mg/dL c | 0.04 (0.02–0.12) | 0.04 (0.01–0.12) | 0.03 (0.01–0.12) | .04 | .05 | .02 |
eGFR, mL/min b | 132.31±21.96 | 136.28±35.07 | 135.58±31.67 | .82 | .31 | .88 |
Urine albumin‐to‐creatinine ratio c | 5.3 (4.6–6.1) | 5.2 (4.5–6.3) | 5.0 (4.2–5.8) | .45 | .53 | .61 |
aContinuous variables presented as mean±standard deviation and categorical variables presented as percentage (number). P values calculated by weighted least‐squares or weighted logistic regression analyses.
bEstimated glomerular filtration rate (eGFR) estimated using Schwartz formula.
cPresented as median (interquartile range).